Subscribe free

Newsletter

Upper Gastrointestinal Tract

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg Oncol30 Dec 2023

Neoadjuvant Chemotherapy Improves Survival in Diffuse Type Gastric and Gastroesophageal Junction Carcinoma

Multimodal therapy, specifically neoadjuvant chemotherapy, was associated with increased survival in patients with diffuse type gastric and gastroesophageal junction carcinoma, including signet ring cell carcinoma. All-cause mortality within 90 days postoperatively was lower after neoadjuvant chemotherapy compared to primary surgery. Additionally, mortality remained lower in…

Am J Gastroenterol27 Dec 2023

Racial Disparity in Esophageal Cancer Treatment and Survival

Black individuals with esophageal squamous cell carcinoma (ESCC) have a lower survival rate compared to white individuals. This disparity could be attributed to presenting at a later stage of the disease and differences in treatment received, including chemotherapy, radiation, and surgery. Black individuals were less…

Gastrointest Endosc27 Dec 2023

Safety and Efficacy of Percutaneous Jejunostomy Tube Placement Outperforms Surgical Methods

A retrospective analysis comparing direct percutaneous endoscopic jejunostomy (DPEJ) tube placement with laparoscopic (Lap-J) and open laparotomy (Open-J) surgical methods revealed similar procedural success rates and complication rates in all three approaches. However, patients who underwent DPEJ experienced significantly lower rates of tube dysfunction within…

Gastrointest Endosc26 Dec 2023

Safety and Efficacy of Percutaneous Jejunostomy Tube Placement Outperforms Surgical Methods

A retrospective analysis comparing direct percutaneous endoscopic jejunostomy (DPEJ) tube placement with laparoscopic (Lap-J) and open laparotomy (Open-J) surgical methods revealed similar procedural success rates and complication rates in all three approaches. However, patients who underwent DPEJ experienced significantly lower rates of tube dysfunction within…

Ann Surg Oncol26 Dec 2023

Patients’ Preferences for Decision Counseling in Esophageal Cancer

Patients with esophageal cancer were offered decision counseling (dc) either before or after neoadjuvant chemoradiotherapy (ncrt) to reflect on their treatment preferences. Interviews with patients revealed that those who received counseling before ncrt were satisfied with the timing, while some patients who received counseling after…